The detection of prostate-specific antigen (PSA) in serum, which was first proposed in the 1970s, is of great importance in the screening of prostate cancer (Albertsen, 2020; Carlsson and Vickers, 2020). The gene discussed is KLK3; the disease is prostate carcinoma.